First Header Logo Second Header Logo

Connection

Karl-Erik Andersson to Carbolines

This is a "connection" page, showing publications Karl-Erik Andersson has written about Carbolines.
Connection Strength

1.537
  1. Zarifpour M, Nomiya M, Sawada N, Andersson KE. Protective effect of tadalafil on the functional and structural changes of the rat ventral prostate caused by chronic pelvic ischemia. Prostate. 2015 Feb 15; 75(3):233-41.
    View in: PubMed
    Score: 0.437
  2. Hood B, Andersson KE. Common theme for drugs effective in overactive bladder treatment: inhibition of afferent signaling from the bladder. Int J Urol. 2013 Jan; 20(1):21-7.
    View in: PubMed
    Score: 0.381
  3. Nomiya M, Burmeister DM, Sawada N, Campeau L, Zarifpour M, Keys T, Peyton C, Yamaguchi O, Andersson KE. Prophylactic effect of tadalafil on bladder function in a rat model of chronic bladder ischemia. J Urol. 2013 Feb; 189(2):754-61.
    View in: PubMed
    Score: 0.380
  4. Andersson KE, de Groat WC, McVary KT, Lue TF, Maggi M, Roehrborn CG, Wyndaele JJ, Melby T, Viktrup L. Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action. Neurourol Urodyn. 2011 Mar; 30(3):292-301.
    View in: PubMed
    Score: 0.338
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.